HC Wainwright Issues Optimistic Estimate for OLMA Earnings
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) – Equities researchers at HC Wainwright upped their Q2 2025 earnings per share (EPS) estimates for shares of Olema Pharmaceuticals in a research report issued to clients and investors on Wednesday, May 14th. HC Wainwright analyst E. Bodnar now forecasts that the company will post earnings of ($0.37) […]
